Kenya among select countries picked by WHO for launch of long-acting HIV vaccine

Kenya among select countries picked by WHO for launch of long-acting HIV vaccine

Notably, Kenya is among the first countries globally to introduce Lenacapavir for HIV prevention, signalling strong international confidence in the country’s health systems and its ability to responsibly deliver cutting-edge medical innovations.

Read more
US considers buying two million shots use in low and middle income countries hard-hit by HIV

US considers buying two million shots use in low and middle income countries hard-hit by HIV

There are more than 30,000 new HIV infections in the US every year and 1.2 million people are living with the virus. Worldwide there are 1.3 million new infections annually and nearly 40 million people living with the virus.

Read more